Literature DB >> 27797302

Treatment of Opioid-Use Disorders.

Marc A Schuckit1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27797302     DOI： 10.1056/NEJMc1610830

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.

Authors:  Michelle R Lofwall; Sharon L Walsh; Edward V Nunes; Genie L Bailey; Stacey C Sigmon; Kyle M Kampman; Michael Frost; Fredrik Tiberg; Margareta Linden; Behshad Sheldon; Sonia Oosman; Stefan Peterson; Michael Chen; Sonnie Kim
Journal:  JAMA Intern Med       Date:  2018-06-01       Impact factor: 21.873

2.  Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.

Authors:  Taeho Greg Rhee
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-11-13       Impact factor: 6.053

3.  Evaluation of opioid discontinuation after non-orthopaedic surgery among chronic opioid users: a population-based cohort study.

Authors:  Naheed K Jivraj; Damon C Scales; Tara Gomes; Jennifer Bethell; Andrea Hill; Ruxandra Pinto; Duminda N Wijeysundera; Hannah Wunsch
Journal:  Br J Anaesth       Date:  2020-01-27       Impact factor: 9.166

Review 4.  Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.

Authors:  Andrew Muzyk; Zachary P W Smothers; Kathryn Collins; Mark MacEachern; Li-Tzy Wu
Journal:  Subst Abus       Date:  2019-08-16       Impact factor: 3.716

Review 5.  [New slow-release buprenorphine formulations for optimization of opioid substitution].

Authors:  Michael Soyka; Oliver Pogarell
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

6.  Predictors and Consequences of Prescription Opioid Use in Women Living With and Without HIV: 20-Year Follow-Up.

Authors:  Mardge H Cohen; Lorie Benning; Kathleen M Weber; Anjali Sharma; Michael Plankey; Mirjam-Colette Kempf; Tracey E Wilson; Brad Aouizerat; Joel Milam; Adaora A Adimora; Gina Wingood; Adam W Carrico
Journal:  J Womens Health (Larchmt)       Date:  2022-02-28       Impact factor: 3.017

7.  Prevalence and treatment of opioid use disorders among primary care patients in six health systems.

Authors:  Gwen Lapham; Denise M Boudreau; Eric A Johnson; Jennifer F Bobb; Abigail G Matthews; Jennifer McCormack; David Liu; Jeffrey H Samet; Andrew J Saxon; Cynthia I Campbell; Joseph E Glass; Rebecca C Rossom; Mark T Murphy; Ingrid A Binswanger; Bobbi Jo H Yarborough; Katharine A Bradley
Journal:  Drug Alcohol Depend       Date:  2019-11-15       Impact factor: 4.492

8.  The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients.

Authors:  Shirley Cohen-Mekelburg; Russell Rosenblatt; Stephanie Gold; Robert Burakoff; Akbar K Waljee; Sameer Saini; Bruce R Schackman; Ellen Scherl; Carl Crawford
Journal:  J Crohns Colitis       Date:  2018-08-29       Impact factor: 9.071

9.  The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder.

Authors:  Heather Palis; Kirsten Marchand; Mohammad Karamouzian; Scott MacDonald; Scott Harrison; Daphne Guh; Kurt Lock; Suzanne Brissette; Aslam H Anis; Michael Krausz; David C Marsh; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Addict Behav Rep       Date:  2018-03-27

10.  Assessing Medical Student Interest in Training About Medications for Opioid Use Disorder: A Pilot Intervention.

Authors:  Jennifer Thomas; Stephanie Slat; Gregory Woods; Kristen Cross; Colin Macleod; Pooja Lagisetty
Journal:  J Med Educ Curric Dev       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.